Patent · US Active

Compounds useful for treating bipolar disorders

US8399708B2 · kind B2 · utility

0Cited by

4References

8Claims

0Family size

Assignee

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. · IL

Inventors

Meir Bialer · Jerusalem, IL
Boris Yagen · Jerusalem, IL

Key dates

Filing date	Jun 15, 2006
Grant date	Mar 19, 2013
Priority date	—
Expiry date	Jul 2, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of valnoctamide (VCD) for the treatment of bipolar disorder and in particular for the treatment of the manic phase of the bipolar disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.